Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 767 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Southern California Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Mid-West Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Operational Excellence (OpEx) Manager (m/f/d), temporary Temporary (Fixed Term), Full time | Production / Manufacturing | Austria | Kundl | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Gulf Coast Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Tehnik vzdrževanja tehničnih storitev II (m/ž/d), Ljubljana Regular, Full time | Production / Manufacturing | Slovenia | Ljubljana | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - New England Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Wisconsin Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Senior QA Expert ESO Temporary (Fixed Term), Full time | Quality | Poland +Alternative Locations | Warsaw | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Chicago Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Tri- State Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
Pagination
- ‹ Previous page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- …
- 77
- › Next page
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى